No surprise, we are not fans of civil RICO. We don’t like how it is misused by lawyers on the other side to convert run-of-the-mill pharmaceutical and medical device cases into class actions. We don’t like that it carries the possibility of treble damages and attorneys’ fees. We don’t like the elasticity of its terms. 
RICO
Are RICO Claims Assignable? Maybe, Maybe Not
We often marvel at how plaintiffs’ attorneys find new ways to sue businesses, including under RICO. Take for example the ever-increasing number of “MSP” plaintiffs that we are seeing in the published opinions. We see plaintiffs called MSP Recovery, MSPA Claims, MSP Series, MSP-MAO, etc., and we are told that many or all of them…
Central District of California Declares Drug Manufacturer Independent From RICO
Tomorrow is the Fourth of July, also called Independence Day, which is when Americans celebrate the independence of the North American colonies from Great Britain. We celebrate American independence on July 4 because the Second Continental Congress adopted the Declaration of Independence on that date in 1776, although it was not signed until about a…
C.D. Cal. Bids Arrivederci to Civil RICO Claim
Last week, in the course of discussing a vaccine case, we mused over the misuse of the due process clause of the fourteenth amendment. Just for a moment we were back at U. of Chicago Law (and, as Dan Fogelberg sang, “felt that old familiar pain”). In 1984, our waist and forehead seemed smaller…
RICO Claims Whacked In Another Zantac Ruling
Guest Post – Paint It Black: The Ninth Circuit OKs RICO Liability For Failure To Warn About Drug Safety Risks
Today’s guest post, about a bottom-ten RICO third-party payor action from (no surprise) the Ninth Circuit, is by long-time friend of the blog (and blogger in his own right), Jonah M. Knobler, of Patterson Belknap. We named one similar case, Kaiser Foundation Health Plan, Inc. v. Pfizer, Inc., 712 F.3d…
The First Circuit Creates Havoc By Ignoring Facts And An Elephant In The Room
We all know the phrase “the elephant in the room.” There are some things that do not get mentioned that are so obviously relevant that silence about them, or willful ignorance of them, can be humorous or frustrating. Based on our not-so-extensive research, we see that the origin of the fairly widespread use of this…
On Prevention of Federal Fraud on the FDA Claims That Avoid Buckman
Private plaintiffs love to scream “fraud on the FDA”! Agency fraud is their magic potion for dissolving any FDA action that they don’t like. Just assert that the FDA was bamboozled and invite some jury somewhere to ignore what the FDA actually did. Unfortunately for the other side, Buckman Co. v. Plaintiffs Legal Committee,…
Can We Play, Too?
Not too long ago we read a non-drug/device decision, Hale v. State Farm Mutual Automobile Insurance Co., 2018 WL 3241971 (S.D. Ill. July 3, 2018), which left us shaking our heads. How this suit could not be a blatant First Amendment violation is beyond us.
But that’s not really the point of this post.…
More Adventures In Personal Jurisdiction − Examining The BMS “Federal Court” Caveat
We’ll be hitting all the Presidents’ Day sales today, but something tells me we’ll be disappointed because we won’t be able to buy, beg, borrow, or steal a new one. So we keep trying.
With plaintiffs desperate to find some way to continue pursuing aggravated, aggregated product liability litigation in their favorite venues after Daimler …